Furthermore, its combination with antioxidants may function synergistically to reduce ROS production and significantly dampen the pathological mechanisms underlying aberrant TGF-β signaling in FECD, potentially rescuing normal TGF-β signaling. The gene discussed is TGFB1; the disease is Fuchs endothelial corneal dystrophy.